Lille Cedex

• TRAUMADORNASE A Prospective, Randomized Multicenter, Double Blind Clinical Trial Comparing Inhaled Dornase Alfa and Its Placebo to Reduce th … Recruiting
  2024-512034-14-00 5 2019-03-04 severe trauma
• Avoid Anticoagulation After IntraCerebral Haemorrhage Recruiting
  2024-514094-22-00 5 2019-01-18 Intrecerebral Haemorrhage
• A multicenter trial where patients with CML stop medication a second time. Recruiting
  2024-515409-25-00 4 2018-01-11 Chronic myeloid leukemia
• Study in which all the patients take the same investigational drug with the aim of evaluate the long-term safety, tolerability, and efficacy … Recruiting
  2023-504520-26-00 5 2017-10-19 Duchenne Muscular Dystrophy (DMD)
• CAR T-cell therapy long term follow-up Recruiting
  2023-508128-37-00 5 2017-07-19 All patients who have been treated with Novartis or Penn CAR T-cell th
• GRAALL2014 Recruiting
  2024-516103-16-00 4 2015-12-04 Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)
• ALL SCTped 2012 FORUM - Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia Recruiting
  2024-512657-24-00 10 2014-03-27 Acute Lymphoblastic Leukaemia
• Hyperthermic Intraperitoneal Chemotherapy in the treatment of Ovarian Cancer relapse Recruiting
  2024-517390-24-00 5 2011-04-26 Ovarian epithelial cancer : intraperitoneal resectable relapse
• PEHRICCA : PErioperative CISGEM plus RILVEGOSTOMIG in High-Risk resectable Intrahepatic CholangioCarcinoma Ended recruitment
  2025-521302-17-00 10 2026-05-26 Hihg risk of cholangiocarcinoma intra hépatic resectable
• Prospective multicenter randomized controlled double-blind label study of the prophylaxis of recurrent pouchitis after fecal microbiota tran … Ended recruitment
  2024-517078-52-00 5 2026-01-19 Patients operated with an IPAA for ulcerative colitis woth active recu
• Phase 3 trial aimed at improving the overall survival of AML in adults aged 18 to 60 by comparing high-dose idarubicin with daunorubicin at … Ended recruitment
  2024-516873-57-00 10 2026-01-13 Acute myeloid leukemia in adults aged 18 to 60
• A Phase 3 Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 Years of Age With Severe Alopecia Areata Ended recruitment
  2024-515438-33-00 5 2026-01-12 Alopecia areata
• A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Safety of Epicutaneous Immunotherapy with DBV712 250 µg in 1-thr … Ended recruitment
  2025-521697-34-00 5 2025-12-01 Peanut allergy
• An interventional, multicenter, and international phase 1/2, light-dose-escalation study to investigate the safety and feasibility of intrao … Ended recruitment
  2025-520563-41-00 7 2025-09-29 High-grade glioma Glioblastoma
• A Phase 3, placebo-controlled study to investigate LP352 in children and adults with Developmental and Epileptic Encephalopathies Ended recruitment
  2024-516412-17-00 5 2025-08-26 Developmental and Epileptic Encephalopathies (DEE)
• A study to assess the efficacy and safety of Empasiprubart versus IVIg in adults with Multifocal Motor Neuropathy Ended recruitment
  2024-516473-72-00 5 2025-07-31 Multifocal Motor Neuropathy
• Rezafungin for treatment of chronic pulmonary aspergillosis (CPA) in adults with limited treatment options Ended recruitment
  2024-519575-26-00 4 2025-07-25 Chronic pulmonary aspergillosis (CPA)
• A multicentre, randomised, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of BP1.4979 in adult p … Ended recruitment
  2024-517987-46-00 4 2025-07-21 Essential tremor
• Phase 2 Study of CVN424 Ended recruitment
  2024-516811-25-00 4 2025-05-15 Parkinson Disease
• A trial of Lu AF82422 in Participants with Multiple System Atrophy (MSA) Ended recruitment
  2024-517169-18-00 5 2025-04-10 Multiple System Atrophy
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell L … Ended recruitment
  2022-501489-24-00 5 2025-03-28 First-line treatment of adult subjects with high-risk large B-cell lym
• A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE) Ended recruitment
  2024-515741-42-00 5 2025-03-28 hereditary angioedema due to C1 esterase inhibitor deficiency (Type 1
• CHAPTER-3 – A randomised clinical trial to assess efficacy and safety of deucrictibant treatment in prophylaxis against HAE attacks in adult … Ended recruitment
  2024-516247-62-00 5 2025-03-10 Hereditary Angioedema
• STEP TEENS Weight Maintenance: A research study on how well semaglutide helps teenagers with excess body weight to lose weight and maintain … Ended recruitment
  2023-508055-40-00 6 2025-02-18 Obesity

Showing 361–384 of 688 trials